TB diagnostic tests--history

Slides:



Advertisements
Similar presentations
TB Disease and Latent TB Infection
Advertisements

Global Consultation on the Implementation of the Xpert MTB/RIF system for rapid diagnosis of TB and MDR-TB M. Akhalaia, MD, Microbiologist, Reference.
QuantiFERON®-TB Gold Test
Nucleic Acid Amplification Test for Tuberculosis
Latent TB When infected with M Tuberculosis, but do not have active tuberculosis disease. Patients are not infectious. TB infections in Australia are predominantly.
Foundations in Microbiology Sixth Edition Chapter 17 Diagnosing Infections Lecture PowerPoint to accompany Talaro Copyright © The McGraw-Hill Companies,
Diagnostic Tests for TB A Comprehensive Overview
Molecular Diagnosis of Infectious Diseases. Why use a molecular test to diagnose an infectious disease? Need an accurate and timely diagnosis Important.
Diagnostic Microbiology and Immunology
New Molecular Based Methods of Diagnosis
Laboratory Investigation
Introduction 1 Laboratory Diagnosis Tuberculosis Dr. Kiarash Ghazvini Department for bacteriology and virology, Mashhad University of medical Sciences.
Allen Kraut, MD, FRCPC Medical Director, Occupational Health WRHA
 Study of the immune system  How the body protects itself against foreign, potentially disease-causing microorganisms  Three main functions:  To recognize.
Laboratory Training for Field Epidemiologists Overview of Microbiology Methods Investigation strategies and methods May 2007.
Volatronic Marketing plan draft.
Laboratory diagnosis of infectious and non infectious diseases The methods employed in the laboratory for diagnosing infectious (bacterial, viral, fungal,
Lab Identification Of Mycobacterium Tuberclosis
Tuberculosis: A disease caused by tiny germs that enter in lungs when someone breath them in. Mycobacterium tuberculosis is a rod shaped, non motile,
American Journal of Respiratory and Critical Care Medicine 2000 Vol. 161, pp
Revision of new diagnostics for TB
LABORATORY DIAGNOSIS OF VIRAL INFECTIONS. In developing countries, virological specimens will need to be transferred from district laboratories to regional.
IGRAs: Should they replace the TST in the identification of latent tuberculosis? Objectives Describe how interferon-gamma release assays (IGRAs) work.
LAB. DIAGNOSIS OF VIRUSES 5 methods are used for diagnosis in the virology laboratory: 1.Direct microscopy 2.Cultivation of viruses 3.Serology 4. Detection.
Tuberculosis Case Study Presenter Xoliswa Poswa TB Laboratory, NHLS/CMID.
DIAGNOSIS CLINICALLAB LAB DIAGNOSIS 1.PUL TUBERCULOSIS SAMPLE COLLECTION MICROSCOPY CONCENTRATION METHODS CULTURE SENSITIVITY TESTS ANIMAL INOCULATION.
Challenge of Diagnosing Smear-Negative TB Department of Infectious Diseases.
professor in microbiology
Mantoux – in vivo detection of specific cell immunity after exposition to antigen - burden of patient by antigen - possible immunodeficiency of patients.
Detection, Prophylaxis and Treatment of Bacterial Infection.
Ghada Barakat.  They are obligate aerobe, rod-shaped, non-motile, non-spore forming, non- capsulated organisms.  Impermeable to various basic dyes,
Laboratory Diagnosis of Tuberculosis By Dr. Faten Aly Shoukry, Ph D Consultant & Head of Microbiology Department, Abbassia Chest Hospital.
Mycobacteria İ. Çağatay Acuner M.D., Clinical Microbiologist, Associate Professor Department of Microbiology Faculty of Medicine, Yeditepe University,
Diagnosis of pulmonary tuberculosis
ZOO405 by Rania Baleela is licensed under a Creative Commons Attribution- NonCommercial-ShareAlike 3.0 Unported LicenseRania BaleelaCreative Commons Attribution-
INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS Identification of Mycobacterium tuberculosis complex in clinical specimens of HIV-infected patients at Instituto.
TB – LABORATORY INVESTIGATIONS by Dr. Zubaidah Abdul Wahab Datin Dr. Ganeswrie Raj 1.
Article review Rapid Molecular Detection of Tuberculosis and Rifampin Resistance [MTB-RIF test] Catharina C. Boehme, M.D., Pamela Nabeta, M.D., Doris Hillemann,
TB: The Elispot In The Room Dr Jessica Potter TB Research Registrar Barts Health NHS Trust.
DIAGNOSIS OF DISEASES AND GENE THERAPY
Foundations in Microbiology Seventh Edition
THE LABORATORY DIAGNOSIS OF VIRAL INFECTIONS
New WHO algorithm to prevent TB deaths in seriously ill patients with HIV Yohhei Hamada TB/HIV and Community Engagement.
TB Disease and Infection
Tuberculosis (TB) PHCL 442 Lab Discussion 4 Raniah Al-Jaizani M.Sc.
Tuberculosis Part 2.
Ch.12 Immunology Applications
Tuberculosis DIAGNOSIS
CASES OF PLEURAL EFFUSION (n=56)
Antibody-Antigen Reactions
Laboratory tests in Genitourinary Tuberculosis
This is an archived document.
Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV- associated pulmonary tuberculosis before antiretroviral therapy:
Principles of Laboratory Diagnosis of Infectious Diseases
ELISA.
LAB. DIAGNOSIS OF VIRUSES
Laboratory Diagnosis of Infectious Diseases
Nucleic Acid Amplification Test for Tuberculosis
Laboratory ‘Network’ Update New York State Department of Health
Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 
Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV- associated pulmonary tuberculosis before antiretroviral therapy:
بسم الله الرحمن الرحيم.
Diagnosing Infections
Which is true about a tuberculin skin test (TST):
Time to update guidelines on screening for latent tuberculosis infection in dermatologic patients being treated with tumor necrosis factor-alfa inhibitors 
Zihua Zeng, Ching-Hsuan Tung, Youli Zu 
Deciphering TB Lab Reports
DIAGNOSIS OF TUBERCULOSIS
TB Screening and Differentiated Service Delivery: State of the Art
The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection  O. Opota, J. Mazza-Stalder,
Presentation transcript:

TB diagnostic tests--history • Microscopy (1880s) • Culture (1880s) • Chest x-ray (1930s) • Tuberculin skin test (Mantoux-1907; PPD- 1939)) • Nucleic acid amplification tests (1990s) • Interferon release assays (2000

Direct demonstration of AFB in sample Diagnosis of TB The key to the diagnosis of tuberculosis is a high index of suspicion. X-Ray Skin Test Direct demonstration of AFB in sample • Growth of TB bacilli in culture

Role of Chest X-ray No chest X-ray pattern is absolutely typical of TB. 10-15% of culture-positive TB patients not diagnosed by X-ray 40% of patients diagnosed as having TB on the basis of x-ray alone do not have active TB

Administering Tuberculin Skin Test Purified protein derivative (PPD) TU PPD tuberculin. Read reaction 48-72 hours after injection Measure only induration Record reaction in millimet

Factors that affect the PPD Reaction Type of Reaction Possible Cause False-positive Nontuberculous mycobacteria BCG vaccination Anergy False-negative Recent TB infection Very young age (< 6 months old) Live-virus vaccination Overwhelming TB disease

AFB Smear Microscopy Microscopy is a simple convenient test Requires minimal infrastructure and equipment • Highly accurate, inexpensive and fast . • Accessible to the majority of patients Prioritizes infectious cases

AFB Smear Microscopy Fluorescence acid-fast staining is more expensive than conventional Ziehl–Neelsen staining but is associated with a higher rate of detection because the slides can be examined faster at lower magnifications.

M. Tuberculosis – the organism Acid fast sputum Acid fast tissue Aurimine fluorescence Scanning electron micrograph of Mycobacterium tuberculosis

Limitations of Microscopy Limitations of Microscopy Can not distinguish between dead or live bacteria . • High bacterial load >3000–5000 AFB 5000 AFB/mL is required for detection • Can not do species identification • Can not perform Drug Sensitivity Test.

Culture Media main types Egg = LJG, LJP, Stone brink, Ogawa Agar = 7H10, 7H11, Blood Liquid = Kirchner, 7H9, 7H12, Dubos New Types= Bactec 460, MGIT, MB BacT . BACTEC 9000 MB system Septi-Chek AFB system (Becton Dickinson)

Radiometric Technology The only well established rapid radiometric method for detecting mycobacteria in clinical specimens is the BACTEC 460TB system (Becton-Dickinson Diagnostic Instruments Systems, Maryland). This system is based on the detection of radioactive carbon-dioxide produced by bacterial metabolism of palmitic acid labelled with carbon 14. Growth of the mycobacteria can be detected within as few as 3 days, and the mean time to detect the M. tuberculosis complex is about 14 days (87-96%)

Radiometric Technology BACTEC system, which employs a superscript 14C-labeled substrate medium that is almost specific for mycobacteria. Instrument Systems, Sparks, Md. has been reported to significantly decrease the time required for detection of mycobacterial TB BACTEC method has provided more rapid growth (average, 9 -14days), specific identification of M. tuberculosis (5 days), and rapid drug susceptibility testing (6 days).

Non-Radiometric Technology BACTEC 9000 MB system (Becton Dickinson).This system uses MYCO/F medium, a modified Middlebrook 7H9 broth.(8-13 days) The system responds to changes in oxygen concentration. Each vial contains a silicon rubber disk, impregnated with a ruthenium metal complex, which serves as an oxygen-specific sensor. Oxygen quenches the fluorescent output of the sensor. Oxygen consumption by microorganisms can be detected by the increase in fluorescence.

Non-Radiometric Technology BACTEC 960 MGIT ,MGITstands for Mycobacteria Growth Indicator Tube, and 960 indicates the total number of culture tubes it can hold at any given time Evaluation of mycobacteria recovery from the fluorometric BACTEC 960 and the radiometric BACTEC 460 TB system have shown that they are more sensitive in recovery of mycobacteria than the conventional L-J and smear microscopy. There is no significant difference between the radiometric BACTEC 460 TB and the fluorometric BACTEC 960 with 91.9% positivity and 95.1% positivity respectively. Results available in 7-14 days

Cytokine Release Assays QuantiFERON-TB GOLD test . Blood samples must be processed within 12 hours after collection while white blood cells are still viable. followed by measurement of Interferon-gamma Assays released by sensitized lymphocytes in an enzyme-linked immunosorbent assay (ELISA). At present, the QuantiFERON-Gold TB test is recommended for screening for latent tuberculosis infection . After incubation of the blood with antigens for 16 to 24 hours, The white blood cells will release IFN-gamma in response to contact with the TB antigens ,the amount of interferon-gamma (IFN-gamma) is measured.

Cytokine Release Assays QuantiFERON-TB GOLD test Should not give false-positive result due to: BCG vaccination Nontuberculous mycobacteria. The test’s performance may be enhanced by the use the Early Secreted Antigen Target -6 (ESAT-6 ) and Culture Filtrate Protien-10 (CPF-10).

The Xpert MTB/RIF TB Test Mean time for Detection of MTB GeneXpert = < day, Microscopy = 1 day, Liquid culture - MGIT = 17 days, Solid Culture = > 30 days Mean time for Detection of Rifampicin Resistance GeneXpert = < 1day Liquid DST = 30 days Conventional DST ( Solid proportional Method) = 75 days

How does the test work? Detects DNA sequences specific for Mycobacterium Tuberculosis and Rifampicin resistance by PCR Based on Nucleic Acid Amplification Test (NAAT). The Xpert® MTB/RIF purifies concentrates amplifies (by real-time PCR) and identifies targeted nucleic acid sequences in the Mycobacterium tuberculosis genome,

The Xpert MTB/RIF TB Test The Xpert MTB/RIF is a cartridge-based, automated diagnostic test that can identify Mycobacterium tuberculosis  (MTB) and resistance to rifampicin (RIF). In December 2010 WHO endorsed the Xpert MTB/RIF technology and released a recommendation and guidance

The Xpert MTB/RIF TB Test The Xpert MTB/RIF is a cartridge-based, automated diagnostic test that can identify Mycobacterium tuberculosis  (MTB) and resistance to rifampicin (RIF). In December 2010 WHO endorsed the Xpert MTB/RIF technology and released a recommendation and guidance

Rapid tests immunochromatographic assays lateral-flow tests or simply strip tests 1- Add 40 µl of serum or plasma sample to the T (Test) area of the test card add 1 drop of sample to the T (Test) area . 2- Follow sample addition with 2 drops of the diluent provided in the dropper bottle by holding the bottle vertically over the T (Test) Area. 3- Results are then read in as little as 20 minutes.

Rapid tests immunochromatographic assays 1- Add 40 µl of serum or plasma sample to the T (Test) area of the test card add 1 drop of sample to the T (Test) area . 2- Follow sample addition with 2 drops of the diluent provided in the dropper lateral-flow tests (strip tests) Results are then read in as little as 20 minutes.

ESAT-6 and CFP10 Mycobacterium tuberculosis-specific antigens (ESAT-6 and CFP10) in experimental animals as well as during natural infection in humans and cattle. combination of ESAT-6 and CFP10 was found to be highly sensitive and specific for both in vivo and in vitro diagnosis. In humans, the combination had a high sensitivity (73%) and a much higher specificity (93%) for active tuberculosis than PPD (7%).

Enzyme-linked immunospot assay T-cell–based interferon-γ release assay The ELISpotPLUS assay incorporates a novel region of difference-1 encoded antigen, Rv3879c, alongside the ESAT-6 and CFP10. ELISpotPLUS sensitivity is 89% higher than that of the standard ELISpot. The combined sensitivity of ELISpotPLUS and tuberculin skin testing in confirmed and highly probable cases of TB was 99%.

Serologic Diagnosis of Tuberculosis ELISA measurement of Ig antibody to mycobacterial antigens Antigen 60 IgG measurement Antigen 38kda IgG Antigen Kp90 IgA &measurement Antigen 60 IgG  seemed to be superior to the others (i.e., the cutoff value was justified by both the sensitivity and the specificity . Am. J. Respir. Crit. Care Med., Volume 156, Number 3, September 1997, 906-911

Serologic Diagnosis of Tuberculosis Antituberculous glycolipid antigen TBGL. The lipoarabinomannan (LAM) polysaccharide antigen. Antigen 60 (A60), which is derived from purified protein derivatives. The combination of LAM, A60, and TBGL appears to be the best choice of antigens for the serodiagnosis of TB

Chemical Detection of Biologic Compounds Adenosine deaminase, a host enzyme produced by activated T cells and easily detected by a colorimetric procedure, was shown to increase in concentration during the active stages of tuberculous meningitis and to decrease to normal levels after effective antituberculosis therapy. A more complicated technology detects the presence of tuberculostatic acid in the spinal fluid or serum of patients.

Gen-Probe AMPLIFIED TM The MTT&MTD are chemical tests, the amplification is to produce sufficient nucleic acid, within a few hours, these tests can recognize MTC in an AFB-positive specimen, with nearly 96% sensitivity and 100% specificity. The NAA result can be falsely negative if there are very few tubercle bacilli, NAA test can amplify DNA from both viable and non-viable organisms.

Gen-Probe AMPLIFIED TM Polymerase chain reaction (PCR) Yield 95% of smear+ and only 50% of smear negatives. main advantages: speed + sensitivity sensitivity : in principle able to pick up 1 TB bacillus in practice : less sensitive than culture Serve only the diagnosis not monitor the treatment outcome Cannot replace culture Not able to determine infectiousness. Very expensive ($50-$100 per assay)

Real-time Polymerase Chain Reaction Techniques Real-time PCR methods are based on hybridization of amplified nucleic acids with fluorescent-labelled probes spanning DNA regions of interest and monitored inside thermal cyclers. The main advantage of real-time PCR methods is its speed in giving results,1.5-2.0 h after DNA extraction.

Non-molecular Techniques The FastPlaque Tuberculosis Assay The FastPlaque TB assay , relies on the ability of M. tuberculosis to support the growth of an infecting mycobacteriophage. The assay have shown a sensitivity of 50-65% in smear-negative specimens with specificity of 98% . It is a rapid, manual test, easy to perform and has a higher sensitivity than microscopy, in newly diagnosed smear +ve pts. Int J Tuberc Lung Dis 1998;2: 160